Persist AI
YC W23 ↗Sacramento, US · Founded 2022 · 6 employees · 7 known investors
Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
AI & Machine LearningBiotechHealthtechMedical DevicesRoboticsMachine LearningMicrofluidicsNanotechnologyTherapeuticsin /persist-ai/@ycombinatorycombinator.com ↗
Founders & leadership· Y Combinator alumni (W23)
KR
Karthik RamaninFounder
CS
Christopher ShelnerinFounder
Investors · 7
Reported raises · per SEC filings
Form D private placements$4.9MraisedApr 2023 · 27 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Grayscale Views Strategy’s Bitcoin Sales As Step Toward Restoring Financing Confidence But Capital Allocation Questions Persist | Crowdfund Insidercrowdfundinsider.com · 2026
- Persist AI raises $12 million to fix drug formulationamericanbazaaronline.com · 2025
- Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Fundingprnewswire.com · 2025
- Persist AI Raises $12M in Series A Fundingfinsmes.com · 2025
- Beyond the $12M: Revolutionizing Drug Formulation Development at Persist AIpersist-ai.com · 2025
- AI-driven drug formulation startup, Persist AI, raises $4M in oversubscribed funding round — TFNtechfundingnews.com · 2023
- Persist AI Raises $4M in Seed Financing to Revolutionize Drug Formulationpersist-ai.com · 2023
- Persist - We build long-lasting drugs 50% faster 💊ycombinator.com · 2023